Episode Details

HealthEquity, Inc. Q1 FY2027 earnings breakdown - conversational walkthrough with a price-aware verdict and Wall Street consensus comparison. THE CALL: BUY (4/5 conviction, STRONG) - CURRENT @ $90.52 -> BUY - BUY below $88.00 with $72.00 stop - AVOID above $120.00 TRIGGER: Q2 FY27 print confirms double-digit custodial revenue growth AND adjusted EBITDA margin holds near 40 percent WINDOW: 12-18 months - FY27 earnings compounding plus a re-rate toward the $110 target WALL STREET CONSENSUS - Ratings: 1 Strong Buy / 24 Buy / 1 Hold / 1 Sell / 0 Strong Sell -> BUY - Median 12-month PT: $110.00 (range $89 - $125) THESIS HealthEquity is the largest HSA custodian in the United States, with over eleven million total accounts and a custodial cash base that earns net interest income, compounding GAAP earnings in the low-thirties percent year over year. Bull lever: Custodial revenue, the net interest income on HSA cash, grew double digits and operating margin hit twenty nine percent; the company redeemed its convertible debt to a net-cash balance sheet while compounding accounts. Key risk: Custodial net interest income is rate-sensitive; a sharp rate-cut cycle compresses yields, and headline revenue growth is mid-single-digit-plus, slower than richer-multiple HCM peers. KEY METRICS - Q1 FY2027 - Revenue: $354.6M (+7.2% YoY) - Diluted EPS: $0.82 (vs $0.74 est, +32% YoY) - Net income: +28.8% YoY - GAAP Operating margin: 29.0% - Free Cash Flow: $97.2M; FCF margin 27.4% - HSA accounts and custodial cash drive recurring service, custodial and interchange revenue - Custodial net interest income is the rate-sensitive swing factor on the model DISCLAIMER This is for informational and educational purposes only. Not financial advice. Charged Alpha does not have a position in HQY. #HQY #HealthEquity #earnings #investing #stocks #ChargedAlpha #HSA #Fintech